These high-quality small-cap firms may deserve a place on your watchlist.
These high-quality dividend payers are the newest entrants to the index, and we take a closer look at three that are undervalued today.
We take an in-depth look at the new constituents of Morningstar's Wide Moat Focus Index and highlight the stocks that are most attractive today.
Despite the dour headlines, we see buying opportunities in these real estate investment trusts.
Uncertainties regarding healthcare loom large, but we think these profitable stocks are being punished too harshly.
As stocks of traditional retailers continue to founder, investors are underappreciating these versatile brands.
These are some of our favorite exchange-traded funds for investors seeking to add or augment their portfolio's international-stock exposure.
Apple may be fairly valued after hitting record highs, but we think these technology stocks are undervalued.
We'd love to own these stocks if they were cheaper, but they are overvalued relative to our fair value estimates.
We take a closer look at valuations among stocks in the Morningstar Dividend Yield Focus Index and highlight a few of the most undervalued stocks.
We take an in-depth look at the new constituents of Morningstar’s Wide Moat Focus Index and highlight the stocks that are most attractive today.
We've cut or boosted the economic moat ratings and trends for more than a dozen companies, and these four firms look undervalued.
Surveying the fund and ETF landscape, from direct hedges like TIPS to indirect inflation-fighting plays such as floating rate loans and commodities.
We don't share investors' convictions in these widely held mutual funds.
We've adjusted our take on the competitive advantages of these undervalued firms.
We highlight three exchange-traded funds that are best-of-breed, and one that falls short relative to peers.
Many banks reported good third-quarter earnings and upbeat outlooks. We check them against Morningstar analysts' expectations.
We take an in-depth look at the new constituents of Morningstar's index of competitively advantaged firms trading at favorable prices.
Six foreign stocks that are selling at compelling valuations.
These stocks have sold off as they face various headwinds, but we think they're trading at attractive valuations.
Drug pricing concerns have indiscriminately weighed on healthcare stocks; these names look undervalued.
We highlight a few of the cheapest stocks in the Morningstar Dividend Yield Focus Index.
While faster-trading funds' sustainability scores could prove ephemeral, these offerings are likely to retain high marks.
Even though they're 65-plus, these funds still make the short list for Morningstar's analysts.
These active and index funds/ETFs offer decent yields and don't take crazy risks.
Active and index dividend-growth options for investors who are on the outside looking in.
Although they've been around for less than five years, many of these funds benefit from a wealth of experience.
We'd love to own these stocks--if only they were cheaper.
These counterpunching funds deliver the income, but it's apt to come with a big dose of volatility.
When markets sell off indiscriminately, we look for the highest-quality bargains.
With some bond experts arguing emerging-markets credits are cheap, we highlight two targeted and two more diffuse options.
These stocks are undervalued based on a half-dozen valuation metrics.
Small companies have been on a roll, but these stocks still look undervalued.
These wide-moat stocks are all trading at least 25% below their fair value estimates.
These sturdy bond funds ply cautious strategies designed to minimize risk.
These international funds have solid records of downside protection and competitive long-term returns, too.
These funds won't keep you up at night if you're squeamish about exposing the bulk of your assets to the market.
These stocks are all expensive based on their prices relative to Morningstar’s fair value estimates.
Their near-term performance may not compel, but a reopening can be a good buying opportunity.
These four firms have wide moats, strong profitability, and reasonable valuations today.
Morningstar's Russ Kinnel, Ben Johnson, and Elizabeth Collins discuss their favorite investment ideas among mutual funds, ETFs, and stocks.
These high-conviction funds also have high-conviction portfolios.
They've had the wind at their backs over the short term, and their long-term prospects look bright, too.
These narrow-moat companies with positive moat trends are all trading in 4- and 5-star range.
Whether your goal is lower costs, better tax efficiency, or style purity, these ETFs get the job done.
Surveying direct and indirect hedges, both traditional mutual funds and exchange-traded funds.
The market was unimpressed with the results of these wide-moat companies during earnings season, but we think their positive long-term stories remain intact.
These three Morningstar Medalists proactively limit the tax collector's cut and generate solid risk-adjusted returns.
On the hunt for bond funds that have gained when the equity market has tumbled.
We screen for quality-conscious, defensive-minded funds that have earned their keep in weak markets.